{"id":"https://openalex.org/W1969778374","doi":"https://doi.org/10.1358/dof.2008.033.04.1186448","title":"Monoclonal antibodies in oncological malignancies: Current status and future directions","display_name":"Monoclonal antibodies in oncological malignancies: Current status and future directions","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W1969778374","doi":"https://doi.org/10.1358/dof.2008.033.04.1186448","mag":"1969778374"},"language":"en","primary_location":{"id":"doi:10.1358/dof.2008.033.04.1186448","doi":"https://doi.org/10.1358/dof.2008.033.04.1186448","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2008.033.04.1186448","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111532199","display_name":"Terry Ann Harding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harding, T.-A.","raw_affiliation_strings":["Albany college of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany college of Pharmacy","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054207622","display_name":"Christine Gallati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gallati, C,.","raw_affiliation_strings":["Department of Family and Community Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Family and Community Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097453180","display_name":"Michael Horlacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Horlacher, M.","raw_affiliation_strings":["Albany college of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany college of Pharmacy","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Becker, A.","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Becker, A.","raw_affiliation_strings":["Albany college of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany college of Pharmacy","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032045966","display_name":"Shaker A. Mousa","orcid":"https://orcid.org/0000-0002-9294-015X","observed_orcids":["https://orcid.org/0000-0002-9294-015X"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mousa, S.A.","raw_affiliation_strings":["Albany college of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany college of Pharmacy","institution_ids":["https://openalex.org/I365282"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2559,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.63739288,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"4","first_page":"0361","last_page":"0361"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":1.0},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5320000052452087},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.74623703956604},{"id":"https://openalex.org/C148043351","wikidata":"https://www.wikidata.org/wiki/Q4456944","display_name":"Current (fluid)","level":2,"score":0.541996955871582},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43512994050979614},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3669264018535614},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35314276814460754},{"id":"https://openalex.org/C127313418","wikidata":"https://www.wikidata.org/wiki/Q1069","display_name":"Geology","level":0,"score":0.05897626280784607},{"id":"https://openalex.org/C111368507","wikidata":"https://www.wikidata.org/wiki/Q43518","display_name":"Oceanography","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1358/dof.2008.033.04.1186448","doi":"https://doi.org/10.1358/dof.2008.033.04.1186448","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2008.033.04.1186448","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.41999998688697815,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2342536580","https://openalex.org/W2478232144","https://openalex.org/W2514399516","https://openalex.org/W2508811059","https://openalex.org/W2410751020","https://openalex.org/W4210449764","https://openalex.org/W1981272614","https://openalex.org/W2024561182","https://openalex.org/W4302553578","https://openalex.org/W7058506283"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}